Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Therapeutic Innovation & Regulatory Science|September 21, 2024
Comparison of Product Features and Clinical Trial Designs for the DTx Products with the Indication of Insomnia Authorized by Regulatory AuthoritiesTakashi Hosono, Yuki Niwa, Masuo KondohOncology Letters|April 29, 2016
<i>N</i>-glycosylation of R-spondin1 at Asn137 negatively regulates its secretion and Wnt/β-catenin signaling-enhancing activityMiyu Tsuchiya, Yuki Niwa, Siro SimizuCancer Science|June 15, 2018
Integrin β1 is an essential factor in vasculogenic mimicry of human cancer cellsRyota Kawahara, Yuki Niwa, Siro SimizuOrganic Letters|May 8, 2015
Phase-vanishing method with acetylene evolution and its utilization in several organic synthesesRyosuke Matake, Yuki Niwa, Hiroshi MatsubaraMolecular Biology of the Cell|January 15, 2016
Identification of DPY19L3 as the C-mannosyltransferase of R-spondin1 in human cellsYuki Niwa, Takehiro Suzuki, Naoshi Dohmae, et al.FEBS Letters|October 2, 2015
O-Fucosylation of CCN1 is required for its secretionYuki Niwa, Takehiro Suzuki, Naoshi Dohmae, et al.FEBS Letters|February 15, 2015
Pirin regulates epithelial to mesenchymal transition independently of Bcl3-Slug signalingKuniya Komai, Yuki Niwa, Yukiko Sasazawa, et al.Health Economics Review|November 27, 2025
Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugsKento Takamura, Gai Jinnai, Yuki Niwa, et al.Journal of Medical Internet Research|October 7, 2025
Magnitude of the Digital Placebo Effect and Its Moderators on Generalized Anxiety Symptoms: Systematic Review and Meta-AnalysisTakashi Hosono, Rinka Tsutsumi, Yuki Niwa, et al.FEBS Letters|June 8, 2012
Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cellsTamami Yasukagawa, Yuki Niwa, Siro Simizu, et al.Pageof 5